Mirvetuximab Soravtansine Dosing Weight Considerations.
Document Type
Article
Publication Date
2025
Publication Title
Journal of Oncology Pharmacy Practice
First Page
10781552251385081
Last Page
10781552251385081
Recommended Citation
Kintzel PE, Myzienski A, Ice LL. Mirvetuximab soravtansine dosing weight considerations. J Oncol Pharm Pract. 2025:10781552251385081. doi: 10.1177/10781552251385081. PMID: 41066425.
DOI
10.1177/10781552251385081
ISSN
1477-092X
PubMed ID
41066425
COinS